Bovine milk xanthine oxidase

Manufactured by Merck Group

Sourced in Italy

Bovine milk xanthine oxidase is a laboratory reagent derived from bovine milk. It is an enzyme that catalyzes the oxidation of hypoxanthine to xanthine and xanthine to uric acid. This enzyme is commonly used in biochemical research and analyses.

Automatically generated - may contain errors

Lab products found in correlation

Spelling variants of this product

Xanthine (244 citations) Xanthine oxidase (219 citations) Xanthine oxidase from bovine milk (21 citations) Bovine milk (19 citations) Bovine xanthine oxidase (2 citations) Xanthine oxidase (XOD) from bovine milk (2 citations)

2 protocols using bovine milk xanthine oxidase

Modulating Oxidative Stress in Ischemia-Reperfusion

Check if the same lab product or an alternative is used in the 5 most similar protocols

To evaluate the role of NO, spermine NONOate (NO donor), or 3-bromo-7-Nitroindazole (NOS inhibitor) (Cayman Chemical) was included in the perfusion medium with and without OGD. To evaluate the role of O₂^•−, hypoxanthine-xanthine oxidase (HX-XO) system was used to generate O₂^•−: Bovine milk xanthine oxidase (≥0.4 units/mg protein) and hypoxanthine (≥99.0%) was obtained from Sigma. O₂^•− was decreased by the addition of the superoxide dismutase (SOD) mimetic 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPOL) obtained from Sigma-Aldrich Corp. FeTMPyP (Cayman Chemical), a synthetic porphyrin complexed with iron is an ONOO⁻ decomposition catalyst and was used to decrease peroxynitrite in the microchamber.

Bhowmick S, & Drew K.L. (2017). Arctic Ground Squirrel resist peroxynitrite-mediated cell death in response to oxygen glucose deprivation. Free radical biology & medicine, 113, 203-211.

+ Open protocol

+ Expand

Synthesis and Characterization of Novel Acetylcholinesterase Inhibitors

Cited 1 time

Check if the same lab product or an alternative is used in the 5 most similar protocols

Human monoamine oxidase A and B, bovine milk xanthine oxidase, kynuramine, xanthine, donepezil, clorgyline, selegiline, and allopurinol were purchased from Sigma-Aldrich (Milan, Italy).
HT hybrids were synthesized, purified, and analyzed as previously reported [49 (link)]. The set was composed of the following seven new compounds: 3,4-dihydroxyphenetyl 1-benzylpiperidine-4-carboxylate (HT1) and its peracetylated form (HT1a), 4,5-dihydroxy-2-nitrophenethyl 1-benzylpiperidine-4-carboxylate (HT2), 4-hydroxy-3-methoxyphenethyl 1-benzylpiperidine-4-carboxylate (HT3) and its peracetylated form (HT3a), and 4-hydroxyphenethyl 1-benzylpiperidine-4-carboxylate (HT4) and its peracetylated form (HT4a). A 50 mM stock solution of each compound was prepared in DMSO.

D’Errico A., Nasso R., Rullo R., Maiuolo J., Costanzo P., Bonacci S., Oliverio M., De Vendittis E., Masullo M, & Arcone R. (2024). Effect of Hydroxytyrosol Derivatives of Donepezil on the Activity of Enzymes Involved in Neurodegenerative Diseases and Oxidative Damage. Molecules, 29(2), 548.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!